For research use only
| Cat No. | ABC-X0278C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human BRAF (L597Q) BAF3 Cell Line facilitates research on BRAF mutations involved in MAPK pathway activation and targeted cancer therapies.
Human BRAF (L597Q) BAF3 Cell Line is a genetically engineered model derived from murine pro-B Ba/F3 parental cells based on customers’ requirement. BRAF (L597Q) BAF3 overexpression cell line is generated by stable integration of exogenous human BRAF containing the L597Q mutation using lentiviral transduction. Overexpression clone is validated at gene level by qRT-PCR.
Target
BRAF encodes a serine/threonine-protein kinase that activates MEK and ERK in the MAPK signaling pathway. The L597Q mutation is a kinase-activating variant found in cancers such as melanoma and colorectal cancer. It contributes to aberrant cell growth and transformation. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0278C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The BRAF (L597Q) BAF3 Cell Line is a robust platform for dissecting mutation-specific BRAF signaling, drug response profiling, and evaluation of RAF and MEK inhibitors in cancers with non-V600 BRAF alterations.